SBFM
SBFM
NASDAQ · Biotechnology

Sunshine Biopharma Inc

$1.01
-0.01 (-0.98%)
Financial Highlights (FY 2026)
Revenue
241.42M
Net Income
-35,540,980
Gross Margin
30.6%
Profit Margin
-14.7%
Rev Growth
+434.8%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 30.6% 61.7% 61.7% 61.7%
Operating Margin -16.7% 14.3% 13.3% 12.7%
Profit Margin -14.7% 9.5% 9.5% 12.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 241.42M 953.7K 857.2K 883.5K
Gross Profit 73.87M 588.6K 529.1K 545.3K
Operating Income -40,244,137 136.7K 113.8K 112.4K
Net Income -35,540,980 90.7K 81.5K 110.3K
Gross Margin 30.6% 61.7% 61.7% 61.7%
Operating Margin -16.7% 14.3% 13.3% 12.7%
Profit Margin -14.7% 9.5% 9.5% 12.5%
Rev Growth +434.8% +23.3% +22.6% +12.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 3.14M 2.46M 3.00M
Total Equity 4.51M 5.12M 4.93M
D/E Ratio 0.69 0.48 0.61
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -38,686,922 169.7K 158.3K 158.7K
Free Cash Flow 104.6K 58.4K 79.5K